(Q53192227)

12 May 2018

title

Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up. (English)

1 reference

12 May 2018

1 reference

1 reference

Jost Langhorst

1

1 reference

12 May 2018

Twyla Mueller

2

1 reference

12 May 2018

Rainer Luedtke

3

1 reference

12 May 2018

Ulla Franken

4

1 reference

12 May 2018

Anna Paul

5

1 reference

12 May 2018

Andreas Michalsen

6

1 reference

12 May 2018

Manfred Schedlowski

7

1 reference

12 May 2018

Gustav J Dobos

8

1 reference

12 May 2018

Sigrid Elsenbruch

9

1 reference

12 May 2018

publication date

1 June 2007

1 reference

12 May 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

12 May 2018

volume

42

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

734-745

1 reference

12 May 2018

https://api.crossref.org/works/10.1080%2F00365520601101682

1 reference

Determinants of life satisfaction in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn's disease: main results of the German Prospective Multicenter Psychotherapy Treatment study on Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Relaxation training as a treatment for chronic pain caused by ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Evaluation of a psychological treatment for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Providing disease-related information worsens health-related quality of life in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

The Symptom Check-List-90-R (SCL-90-R): a German validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Psychological stress and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Heightened responses to stressors in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520601101682

10.1080/00365520601101682

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

17505996

1 reference

12 May 2018